Fermented Camel (Camelus dromedarius) and Bovine Milk Attenuate Azoxymethane-induced Colonic Aberrant Crypt Foci in Fischer 344 Rats
DOI:
https://doi.org/10.3923/pjn.2018.179.189Keywords:
Aberrant crypt foci, azoxymethane, camel milk, colon cancer, dietary chemopreventionAbstract
Background and Objective: Camel milk is a folk remedy that includes valuable nutrients and bioactive zoochemicals. However, the chemopreventive potential of camel milk against colon carcinogenesis is poorly understood. This study was conducted to investigate the chemopreventive potential of camel (Camelus dromedarius) and bovine milk as well as the impact of fermenting these milks with Lactobacillus acidophilus and Streptococcus thermophilus against early colon carcinogenesis as measured by the reduction of aberrant crypt foci (ACF) in azoxymethane (AOM)-treated Fischer 344 rats. Methodology: Each of 60 weanling male rats was assigned to one of 6 experimental diet groups: Fermented and unfermented camel milk with AOM, fermented and unfermented bovine milk with AOM and positive (PC, AOM only) and negative (NC, saline vehicle only) control groups. The animals were fed the corresponding diets for 3 weeks and then received two subcutaneous injections of AOM or vehicle for 2 consecutive weeks and they were then placed on the corresponding diets for 11 weeks. At termination, all rats were euthanized, colons were harvested and the ACF counts were determined for all tested groups. Immunohistochemical testing was then performed to examine cell proliferation and apoptosis in the camel milk groups. Results: Significant reductions (p<0.05) (48.4-62.1%) in the total ACF count were observed in the colons of the rats fed all milk diets compared with rats fed on PC. However, significant differences were not observed in the total ACF between the camel and bovine milk diets or between the fermented and unfermented milk diets. In addition, significant changes were not observed in the apoptotic index for the camel milk diet compared with the index values for PC and β-catenin was generally localized to the membrane in all examined specimens. Conclusion: By virtue of its bioactive components, camel milk exhibited a chemopreventive potential against early colon carcinogenesis, however, fermentation did not improve its chemopreventive potential.
References
WHO., 2014. World cancer report 2014. World Health Organization, Rome, Italy.
Schoen, R.E., P.F. Pinsky, J.L. Weissfeld, L.A. Yokochi and T. Church et al., 2012. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. New Engl. J. Med., 366: 2345-2357.
Ahmed, F.E., 2004. Effect of diet, life style and other environmental/chemopreventive factors on colorectal cancer development and assessment of the risks. J. Environ. Sci. Health, Part C, 22: 91-148.
De Angelis, R.C., I.C.M. Terra and J.V.M. Campos, 1988. The effect of maturation and source of dietary protein on the capacity of the small intestine to hydrolize lactose in rats. Nutr. Res., 8: 1413-1420.
Gill, H.S. and M. Cross, 2000. Anticancer properties of bovine milk. Br. J. Nutr., 84: 161-164.
Parodi, P.W., 1999. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J. Dairy Sci., 82: 1339-1349.
Tsuda, H. and K. Sekine, 2000. Milk components as cancer chemopreventive agents. Asian Pac. J. Cancer Prev., 1: 277-282.
Tsuda, H., K. Sekine, Y. Ushida, T. Kuhara, N. Takasuka, M. Iigo, B.S. Han and M.A. Moore, 2000. Milk and dairy products in cancer prevention: Focus on bovine lactoferrin. Mutat. Res., 462: 227-233.
Shwter, A.N., N.A. Abdullah, M.A. Alshawsh, H.R. El-Seedi and N.A. Al-Henhena et al., 2016. Chemopreventive effect of Phaleria macrocarpa on colorectal cancer aberrant crypt foci in vivo. J. Ethnopharmacol., 193: 195-206.
Al Haj, O.A. and H.A. Al Kanhal, 2010. Compositional, technological and nutritional aspects of dromedary camel milk. Int. Dairy J., 20: 811-821.
Khedid, K., M. Faid, A. Mokhtari, A. Soulaymani and A. Zinedine, 2009. Characterization of lactic acid bacteria isolated from the one humped camel milk produced in Morocco. Microbiol. Res., 164: 81-91.
Yateem, A., M.T. Balba, T. Al-Surrayai, B. Al-Mutairi and R. Al-Daher, 2008. Isolation of lactic acid bacteria with probiotic potential from camel milk. Int. J. Dairy Sci., 3: 194-199.
Salami, M., A.A. Moosavi-Movahedi, F. Moosavi-Movahedi, M.R. Ehsani and R. Yousefi et al., 2011. Biological activity of camel milk casein following enzymatic digestion. J. Dairy Res., 78: 471-478.
Hamad, E.M., E.A. Abdel-Rahim and E.A. Romeih, 2011. Beneficial effect of camel milk on liver and kidneys function in diabetic sprague-dawley rats. Int. J. Dairy Sci., 6: 190-197.
Dallak, M., 2009. Camel's milk protects against cadmium chloride-induced hypocromic microcytic anemia and oxidative stress in red blood cells of white albino rats. Am. J. Pharmacol. Toxicol., 4: 136-143.
Salwa, M.Q. and A.F.K. Lina, 2010. Antigenotoxic and anticytotoxic effect of camel milk in mice treated with cisplatin. Saudi J. Biol. Sci., 17: 159-166.
Sohn, O.S., F.S. Emerich, S.P. Requeijo, J.H. Weisburger and F.J. Gonzalez, 2001. Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res., 61: 8435-8440.
Femia, A.P., C. Luceri, P. Dolara, A. Giannini and A. Biggeri et al., 2002. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis, 23: 1953-1960.
Bird, R.P., 1987. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett., 37: 147-151.
Stevens, R., H. Swede and D. Rosenberg, 2007. Epidemiology of colonic aberrant crypt foci: Review and analysis of existing studies. Cancer Lett., 252: 171-183.
Faris, M.A.I.E., H.R. Takruri, M.S. Shomaf and Y.K. Bustanji, 2009. Chemopreventive effect of raw and cooked lentils (Lens culinaris L.) and soybeans (Glycine max) against azoxymethane-induced aberrant crypt foci. Nutr. Res., 29: 355-362.
Sekine, K., Y. Ushida, T. Kuhara, M. Iigo and H. Baba-Toriyama et al., 1997. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett., 121: 211-216.
Boone, C.W., V.E. Steele and G.J. Kelloff, 1992. Screening for chemopreventive (anticarcinogenic) compounds in rodents. Mutat. Res./Fundam. Mol. Mechan. Mutag., 267: 251-255.
Chen, J. and X.F. Huang, 2009. The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biol. Ther., 8: 1313-1317.
Khan, N., F. Afaq and H. Mukhtar, 2006. Apoptosis by dietary factors: The suicide solution for delaying cancer growth. Carcinogenesis, 28: 233-239.
Jelen, P. and O. Tossavainen, 2003. Low lactose and lactose-free milk and dairy products-prospects, technologies and applications. Aust. J. Dairy Technol., 58: 161-165.
Reeves, P.G., 1997. Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr., 127: 838S-841S.
Musaiger, A.O., 2006. Food Composition Tables for Arab Gulf Countries. Arab Center for Nutrition, National Nutrition Institute, Bahrain, Pages: 180.
Pereira, M.A., L.H. Barnes, V.L. Rassman, G. Kelloff and V. Steele, 1994. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis, 15: 1049-1054.
McLellan, E.A. and R.P. Bird, 1988. Aberrant crypts: Potential preneoplastic lesions in the murine colon. Cancer Res., 48: 6187-6192.
McLellan, E., A. Medline and R. Bird, 1991. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: Putative preneoplastic lesions. Cancer Res., 51: 5270-5274.
Abdel-Rahman, W.M., 2006. Mutations of beta-catenin and KRAS in colorectal carcinomas. Digest. Dis. Sci., 51: 616-617.
Abdel-Rahman, W.M., M. Ollikainen, R. Kariola, H.J. Jarvinen and J.P. Mecklin et al., 2005. Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene, 24: 1542-1551.
Velmurugan, B., R.P. Singh, R. Agarwal and C. Agarwal, 2010. Dietaryâ€feeding of grape seed extract prevents azoxymethaneâ€induced colonic aberrant crypt foci formation in fischer 344 rats. Mol. Carcinog., 49: 641-652.
Sengupta, A., S. Ghosh and S. Das, 2003. Tea can protect against aberrant crypt foci formation during azoxymethane induced rat colon carcinogenesis. J. Exp. Clin. Cancer Res., 22: 181-191.
Rao, C.V., T. Kawamori, R. Hamid and B.S. Reddy, 1999. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis, 20: 641-644.
Magnuson, B.A., I. Carr and R.P. Bird, 1993. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res., 53: 4499-4504.
Pretlow, T.P., M.A. O`Riordan, G.A. Sonich, S.B. Amini and T.G. Pretlow, 1992. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis, 13: 1509-1512.
Rao, C.V., B. Simi and B.S. Reddy, 1993. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis, 14: 2219-2225.
Reddy, B.S., C.V. Rao and K. Seibert, 1996. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569.
Rowland, I.R., C.J. Rumney, J.T.Coutts and L.C. Lievense, 1998. Effect of bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis, 19: 281-285.
Verghese, M., D.R. Rao, C.B. Chawan, L.L. Williams and L. Shackelford, 2002. Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young fisher 344 rats. J. Nutr., 132: 2809-2813.
Davoodi, H., S. Esmaeili and A. Mortazavian, 2013. Effects of milk and milk products consumption on cancer: A review. Comprehens. Rev. Food Sci. Food Safety, 12: 249-264.
Perdigon, G., A.M. de LeBlanc, J. Valdez and M. Rachid, 2002. Role of yoghurt in the prevention of colon cancer. Eur. J. Clin. Nutr., 56: S65-S68.
Abu-Tarboush, H., 1996. Comparison of associative growth and proteolytic activity of yogurt starters in whole milk from camels and cows. J. Dairy Sci., 79: 366-371.
Dziuba, M., B. Dziuba and A. Iwaniak, 2009. Milk proteins as precursors of bioactive peptides. Acta Sci. Pol Technol. Aliment, 8: 71-90.
Tavan, E., C. Cayuela, J.M. Anroine, G. Trugnan, C. Chaugier and P. Cassand, 2002. Effects of diary products on heterocyclic aromatic amine-induced rat colon carcinogenesis. Carcinogenesis, 23: 477-483.
Narushima, S., T. Sakata, K. Hioki, T. Itoh, T. Nomura and K. Itoh, 2010. Inhibitory effect of yogurt on aberrant crypt foci formation in the rat colon and colorectal tumorigenesis in RasH2 mice. Exp. Anim., 59: 487-494.
Xiao, H., X. Hao, B. Simi, J. Ju, H. Jiang, B.S. Reddy and C.S. Yang, 2008. Green tea polyphenols inhibit colorectal Aberrant Crypt Foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis, 29: 113-119.
Hao, X.P., T.G. Pretlow, J.S. Rao and T.P. Pretlow, 2001. β-Catenin expression is altered in human colonic aberrant crypt foci. Cancer Res., 61: 8085-8088.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
